These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2875665)

  • 1. Exacerbation of schizophrenia associated with amantadine.
    Nestelbaum Z; Siris SG; Rifkin A; Klar H; Reardon GT
    Am J Psychiatry; 1986 Sep; 143(9):1170-1. PubMed ID: 2875665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.
    Kornhuber J; Weller M
    J Neural Transm Gen Sect; 1993; 92(1):57-65. PubMed ID: 8101093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients.
    Valevski A; Modai I; Zbarski E; Zemishlany Z; Weizman A
    Clin Neuropharmacol; 1998; 21(6):355-7. PubMed ID: 9844793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
    Hitri A; Craft RB; Sethi R; Sinha D
    Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All antipsychotics are equal, but some are more equal than others.
    Volavka J; Citrome L
    J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in verbal learning of patients with schizophrenia: Results from a randomized, double-blind, placebo-controlled trial of amantadine adjunctive to antipsychotics.
    Czepielewski LS; Sodré L; Souza AC; Bücker J; Burke KP; Ceresér KM; Gama CS
    Schizophr Res; 2015 Oct; 168(1-2):571-2. PubMed ID: 26104472
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of amantadine on prolactin levels and galactorrhea on neuroleptic-treated patients.
    Siever LJ
    J Clin Psychopharmacol; 1981 Jan; 1(1):2-7. PubMed ID: 6117579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
    Silver H; Geraisy N
    Biol Psychiatry; 1995 Sep; 38(6):413-5. PubMed ID: 8547463
    [No Abstract]   [Full Text] [Related]  

  • 11. Abuse and misuse of anticholinergic medications.
    Land W; Pinsky D; Salzman C
    Hosp Community Psychiatry; 1991 Jun; 42(6):580-1. PubMed ID: 1677920
    [No Abstract]   [Full Text] [Related]  

  • 12. Amantadine in the management of extrapyramidal side effects.
    Borison RL
    Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicated chronic schizophrenic patients do not demonstrate left turning asymmetry.
    Levine J; Martine T; Feraro R; Kimhi R; Bracha HS
    Neuropsychobiology; 1997; 36(1):22-4. PubMed ID: 9211440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cabergoline-induced psychotic exacerbation in schizophrenic patients.
    Chang SC; Chen CH; Lu ML
    Gen Hosp Psychiatry; 2008; 30(4):378-80. PubMed ID: 18585544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of novel antipsychotic drugs.
    Raleigh F
    Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report.
    Kane JM; Dauphinais D; Barnes TR; Adler LA; Rifkin A
    Psychopharmacol Bull; 1993; 29(1):45-9. PubMed ID: 8104351
    [No Abstract]   [Full Text] [Related]  

  • 18. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.